BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18343198)

  • 1. Nuclear receptors: doubling up in the lung.
    Farrow SN
    Curr Opin Pharmacol; 2008 Jun; 8(3):275-9. PubMed ID: 18343198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles for lipid-activated transcription factors in atherosclerosis.
    Nagy L; Szanto A
    Mol Nutr Food Res; 2005 Nov; 49(11):1072-4. PubMed ID: 16208627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoid x receptor heterodimers in the metabolic syndrome.
    Shulman AI; Mangelsdorf DJ
    N Engl J Med; 2005 Aug; 353(6):604-15. PubMed ID: 16093469
    [No Abstract]   [Full Text] [Related]  

  • 4. Combinatorial roles of nuclear receptors in inflammation and immunity.
    Glass CK; Ogawa S
    Nat Rev Immunol; 2006 Jan; 6(1):44-55. PubMed ID: 16493426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms.
    Straus DS; Glass CK
    Trends Immunol; 2007 Dec; 28(12):551-8. PubMed ID: 17981503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARs and other nuclear receptors in inflammation.
    Rizzo G; Fiorucci S
    Curr Opin Pharmacol; 2006 Aug; 6(4):421-7. PubMed ID: 16777482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear receptors in macrophages: a link between metabolism and inflammation.
    Szanto A; Roszer T
    FEBS Lett; 2008 Jan; 582(1):106-16. PubMed ID: 18022390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.
    Rigamonti E; Chinetti-Gbaguidi G; Staels B
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1050-9. PubMed ID: 18323516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic opportunities for liver X receptor modulators.
    Collins JL
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):692-702. PubMed ID: 15503871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors and liver X receptors in atherosclerosis and immunity.
    Barish GD
    J Nutr; 2006 Mar; 136(3):690-4. PubMed ID: 16484544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The liver X receptors.
    Lala DS
    Curr Opin Investig Drugs; 2005 Sep; 6(9):934-43. PubMed ID: 16187693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor.
    Moore DD; Kato S; Xie W; Mangelsdorf DJ; Schmidt DR; Xiao R; Kliewer SA
    Pharmacol Rev; 2006 Dec; 58(4):742-59. PubMed ID: 17132852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear receptors, mitochondria and lipid metabolism.
    Alaynick WA
    Mitochondrion; 2008 Sep; 8(4):329-37. PubMed ID: 18375192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of adiponectin receptor 1 in human hepatocytes by agonists of nuclear receptors.
    Neumeier M; Weigert J; Schäffler A; Weiss T; Kirchner S; Laberer S; Schölmerich J; Buechler C
    Biochem Biophys Res Commun; 2005 Sep; 334(3):924-9. PubMed ID: 16023994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear receptors as drug targets in metabolic diseases: new approaches to therapy.
    Tobin JF; Freedman LP
    Trends Endocrinol Metab; 2006 Sep; 17(7):284-90. PubMed ID: 16870465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver.
    Anderson SP; Dunn C; Laughter A; Yoon L; Swanson C; Stulnig TM; Steffensen KR; Chandraratna RA; Gustafsson JA; Corton JC
    Mol Pharmacol; 2004 Dec; 66(6):1440-52. PubMed ID: 15371561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.
    Beaven SW; Tontonoz P
    Annu Rev Med; 2006; 57():313-29. PubMed ID: 16409152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RXR-LXR heterodimer modulators for the potential treatment of dyslipidemia.
    Lagu B; Pio B; Lebedev R; Yang M; Pelton PD
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3497-503. PubMed ID: 17485209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-steroidal steroid receptor modulators.
    Buijsman RC; Hermkens PH; van Rijn RD; Stock HT; Teerhuis NM
    Curr Med Chem; 2005; 12(9):1017-75. PubMed ID: 15892636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The liver X receptor and atherosclerosis.
    Scott J
    N Engl J Med; 2007 Nov; 357(21):2195-7. PubMed ID: 18032771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.